VA Medical Center (111J), One Veteran's Drive, Minneapolis, MN 55417, USA.
Clin J Am Soc Nephrol. 2010 Sep;5(9):1574-81. doi: 10.2215/CJN.01320210. Epub 2010 Jun 10.
To determine, in a national cohort of incident hemodialysis patients, whether meeting a greater number of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guideline goals at dialysis initiation was independently associated, in a graded manner, with lower first-year mortality rates.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients who initiated hemodialysis between June 1, 2005, and May 31, 2007, in the US were included in this retrospective cohort analysis. Guidelines examined were (1) use of arteriovenous fistula or graft at initiation; (2) hemoglobin > or = 11 g/dl; and (3) albumin at goal. The primary predictor variable was number of guideline goals (zero, one, two, or three) met at dialysis initiation. Cox regression analysis was used to compare time to death, adjusting for baseline characteristics.
At dialysis initiation, 59%, 31%, 9%, and 1.6% of patients met zero, one, two, or three guideline goals, respectively (total n = 192,307). After multivariate adjustment, mortality hazard ratios (95% confidence intervals) were 0.81 (0.80 to 0.83) for patients who met one, 0.53 (0.51 to 0.56) for patients who met two, and 0.34 (0.30 to 0.39) for patients who met three guideline goals, compared with patients who met none. Meeting each individual goal was also associated with lower mortality.
These findings suggest a graded association between meeting a greater number of evidence-based guideline goals at dialysis initiation and lower risk of death during the first year on dialysis.
在一项全国性的新进入血液透析患者队列中,确定在透析开始时满足更多的美国国家肾脏病基金会肾脏病预后质量倡议(KDOQI)指南目标是否与较低的第一年死亡率呈分级相关。
设计、设置、参与者和测量:本回顾性队列分析纳入了 2005 年 6 月 1 日至 2007 年 5 月 31 日期间在美国开始血液透析的患者。检查的指南包括:(1)在开始时使用动静脉瘘或移植物;(2)血红蛋白≥11g/dl;(3)白蛋白达标。主要预测变量是在透析开始时满足指南目标的数量(零、一、二或三)。Cox 回归分析用于比较死亡时间,同时调整基线特征。
在透析开始时,分别有 59%、31%、9%和 1.6%的患者满足零、一、二或三个指南目标(总 n=192307)。在多变量调整后,满足一个目标的患者死亡率的危险比(95%置信区间)为 0.81(0.80 至 0.83),满足两个目标的患者为 0.53(0.51 至 0.56),满足三个目标的患者为 0.34(0.30 至 0.39),与未满足任何目标的患者相比。满足每个单独的目标也与死亡率降低相关。
这些发现表明,在透析开始时满足更多基于证据的指南目标与第一年透析期间死亡风险降低之间存在分级关联。